AOSSM Specialty Day 2023 with ISAKOS - no CME-3. AOSSM-ISAKOS - Session III

Video Transcription

Video Summary

In this video, Chuck Hsu from the Stedman Clinic in Vail, Colorado presents research on the revision rate following primary hip arthroscopy. The study compares patients given prophylactic oral Losartan, a medication used to treat hypertension, with those who did not receive it. The research found that patients not taking Losartan had a higher rate of revision surgery, specifically for hip arthroscopy, and all of these revisions included adhesions. However, there was no significant difference in the rate of conversion to total hip arthroplasty between the two groups, nor in patient-reported outcomes. The findings suggest that Losartan may have an antifibrotic effect and could be beneficial in orthopedic surgery. (Word count: 111)

Keywords

revision rate

primary hip arthroscopy

Losartan

adhesions

orthopedic surgery